Key Points
-
Cells of the mononuclear phagocytic lineage differentiate into many different types of macrophage with a wide range of activities. These include specialized types of macrophage, such as Kupffer cells in the liver, microglial cells in the brain, dendritic cells and the highly specialized bone osteoclasts.
-
Macrophages have many functions, including roles in immunity, apoptotic-cell clearance, wound healing and, as discussed in this Review, development.
-
Analysis of macrophage-deficient mice has revealed many functions for these cells in development, and their loss perturbs the morphology and physiology of many tissues, such as the brain, mammary glands and bones.
-
Macrophages promote epithelial-cell outgrowth and branching morphogenesis in several tissues, including the pancreas and the mammary glands.
-
Macrophages regulate angiogenesis during development, wound repair and disease.
-
Macrophages have a role in adipogenesis and obesity.
-
Macrophages are strongly involved in many chronic diseases that are associated with ageing and provide trophic factors that are similar to those used during development; this has the effect of increasing disease pathology.
-
Cancers sequester the developmental roles of macrophages to enhance their growth, invasive capacity, intravasation, progression and metastatic capacity.
Abstract
Specialized phagocytes are found in the most primitive multicellular organisms. Their roles in homeostasis and in distinguishing self from non-self have evolved with the complexity of organisms and their immune systems. Equally important, but often overlooked, are the roles of macrophages in tissue development. As discussed in this Review, these include functions in branching morphogenesis, neuronal patterning, angiogenesis, bone morphogenesis and the generation of adipose tissue. In each case, macrophage depletion impairs the formation of the tissue and compromises its function. I argue that in several diseases, the unrestrained acquisition of these developmental macrophage functions exacerbates pathology. For example, macrophages enhance tumour progression and metastasis by affecting tumour-cell migration and invasion, as well as angiogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
206,07 € per year
only 17,17 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Tauber, A. I. Metchnikoff and the phagocytosis theory. Nature Rev. Mol. Cell Biol. 4, 897–901 (2003).
Kawai, Y., Smedsrod, B., Elvevold, K. & Wake, K. Uptake of lithium carmine by sinusoidal endothelial and Kupffer cells of the rat liver: new insights into the classical vital staining and the reticulo-endothelial system. Cell Tissue Res. 292, 395–410 (1998).
van Furth, R. et al. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells. Bull. World Health Organ. 46, 845–852 (1972). This article formalizes the concept of the MPS.
Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
Hume, D. A. Macrophages as APC and the dendritic cell myth. J. Immunol. 181, 5829–5835 (2008).
Bailey, A. S. et al. Myeloid lineage progenitors give rise to vascular endothelium. Proc. Natl Acad. Sci. USA 103, 13156–13161 (2006).
Hume, D. A. The mononuclear phagocyte system. Curr. Opin. Immunol. 18, 49–53 (2006).
Bertrand, J. Y. et al. Three pathways to mature macrophages in the early mouse yolk sac. Blood 106, 3004–3011 (2005).
Rae, F. et al. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r–EGFP transgene reporter. Dev. Biol. 308, 232–246 (2007). This study examines the transcriptional profile of embryonic macrophages and suggests theirtrophic functions.
Lichanska, A. M. et al. Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1. Blood 94, 127–138 (1999). This paper examines the development of macrophages during embryogenesis.
Dzierzak, E., Medvinsky, A. & de Bruijn, M. Qualitative and quantitative aspects of haematopoietic cell development in the mammalian embryo. Immunol. Today 19, 228–236 (1998).
Perry, V. H., Hume, D. A. & Gordon, S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15, 313–326 (1985).
Sasmono, R. T. et al. A macrophage colony-stimulating factor receptor–green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101, 1155–1163 (2003). This study uses a valuable reporter mouse strain for studying the mononuclear phagocytic system in development and disease.
Cecchini, M. G. et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120, 1357–1372 (1994). This paper provides a detailed characterization of macrophage deficiencies in Csf1op/op mice.
Merad, M., Ginhoux, F. & Collin, M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Rev. Immunol. 8, 935–947 (2008).
Ovchinnikov, D. A. et al. Expression of Gal4-dependent transgenes in cells of the mononuclear phagocyte system labeled with enhanced cyan fluorescent protein using Csf1r–Gal4VP16/UAS–ECFP double-transgenic mice. J. Leukoc. Biol. 83, 430–433 (2008).
Sasmono, R. T. et al. Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1. J. Leukoc. Biol. 82, 111–123 (2007).
Gordon, S. Alternative activation of macrophages. Nature Rev. Immunol. 3, 23–35 (2003). This is a seminal review on the differences in macrophage phenotypes during immune responses.
Mantovani, A., Sozzani, S., Locati, M., Allavena, P. & Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549–555 (2002). The paper suggests that the M1- and M2-type classification for macrophages is applicable to those found in tumours.
Ricardo, S. D., van Goor, H. & Eddy, A. A. Macrophage diversity in renal injury and repair. J. Clin. Invest. 118, 3522–3530 (2008).
Hamilton, J. A. Colony-stimulating factors in inflammation and autoimmunity. Nature Rev. Immunol. 8, 533–544 (2008).
Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nature Rev. Immunol. 8, 958–969 (2008). This is a recent review emphasizing multiple and plastic phenotypes of macrophages, with an emphasis on wound-healing macrophages.
Chitu, V. & Stanley, E. R. Colony-stimulating factor-1 in immunity and inflammation. Curr. Opin. Immunol. 18, 39–48 (2006). An important review of the action of CSF1-regulated macrophages in disease.
Fortier, A. H. & Falk, L. A. Isolation of murine macrophages. Curr. Protoc Immunol. Chapter 14, Unit 14 1 (2001).
Stanley, E. et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl Acad. Sci. USA 91, 5592–5596 (1994).
Dranoff, G. et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 264, 713–716 (1994). In this study and in reference 25, the generation of a mouse lacking GM-CSF indicates that this growth factor does not have a role in the regulation of the myeloid lineage in normal physiological conditions.
Nicola, N. A. et al. Functional inactivation in mice of the gene for the interleukin-3 (IL-3)-specific receptor beta-chain: implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cells. Blood 87, 2665–2674 (1996).
Anderson, K. L. et al. Myeloid development is selectively disrupted in PU.1 null mice. Blood 91, 3702–3710 (1998).
Tondravi, M. M. et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature 386, 81–84 (1997). References 28 and 29 show that the transcription factor PU.1 is important for myeloid-cell development and its absence results in osteopetrosis.
Simon, M. C. PU.1 and hematopoiesis: lessons learned from gene targeting experiments. Semin. Immunol. 10, 111–118 (1998).
Kohyama, M. et al. Role for Spi-C in the development of red pulp macrophages and splenic iron homeostasis. Nature 457, 318–321 (2009).
Pollard, J. W. & Stanley, E. R. Pleiotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic (op). Adv. Develop. Bioch. 4, 153–193 (1996).
Dai, X. et al. Targeted disruption of the mouse CSF-1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primititive progenitor cell frequencies and reproductive defects. Blood 99, 111–120 (2002). In this paper, the phenotype of mice lacking Csf1r indicates the importance of CSF1R in regulating cells of the MPS.
Cohen, P. E., Zhu, L., Nishimura, K. & Pollard, J. W. Colony-stimulating factor 1 regulation of neuroendocrine pathways that control gonadal function in mice. Endocrinology 143, 1413–1422 (2002).
Lin, H. et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807–811 (2008).
Guleria, I. & Pollard, J. W. Aberrant macrophage and neutrophil population dynamics and impaired Th1 response to Listeria monocytogenes in colony-stimulating factor 1- deficient mice. Infect. Immun. 69, 1795–1807 (2001).
Teitelbaum, R. et al. The M cell as a portal of entry to the lung for the bacterial pathogen for Mycobacterium tuberculosis. Immunity 10, 641–650 (1999).
Wiktor-Jedrzejczak, W. et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl Acad. Sci. USA 87, 4828–4832 (1990). This is the original characterization of mice lacking CSF1 because of an inactivating mutation in the Csf1 gene.
Van Wesenbeeck, L. et al. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc. Natl Acad. Sci. USA 99, 14303–14308 (2002).
Dougall, W. et al. RANK is essential for osteoclast and lymph node development. Genes Develop. 13, 2412–2424 (1999). Discovery of the identity and function of the growth factor RANKL for the osteoclastic lineage.
Grey, A., Chen, Y., Paliwal, I., Carlberg, K. & Insogna, K. Evidence for a functional association between phosphatidylinositol 3- kinase and c-src in the spreading response of osteoclasts to colony- stimulating factor-1. Endocrinology 141, 2129–2138 (2000).
Begg, S. K. et al. Delayed hemopoietic development in osteopetrotic (op/op) mice. J. Exp. Med. 177, 237–242 (1993).
Wiktor-Jedrzejczak, W. et al. Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp. Hematol. 19, 1049–1054 (1991).
Marks, S. C. Jr et al. Administration of colony stimulating factor-1 corrects some macrophage, dental, and skeletal defects in an osteopetrotic mutation (toothless, tl) in the rat. Bone 13, 89–93 (1992).
Gouon-Evans, V., Rothenberg, M. E. & Pollard, J. W. Postnatal mammary gland development requires macrophages and eosinophils. Development 127, 2269–2282 (2000).
Ingman, W. V., Wyckoff, J., Gouon-Evans, V., Condeelis, J. & Pollard, J. W. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev. Dyn. 235, 3222–3229 (2006).
Pollard, J. W. & Hennighausen, L. Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc. Natl Acad. Sci. USA 91, 9312–9316 (1994). References 45 and 47 show that macrophages regulate branching morphogenesis in the mammary gland.
Nguyen, A. V. & Pollard, J. W. Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev. Biol. 247, 11–25 (2002).
Banaei-Bouchareb, L. et al. Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. J. Leukoc. Biol. 76, 359–367 (2004).
Geutskens, S. B., Otonkoski, T., Pulkkinen, M. A., Drexhage, H. A. & Leenen, P. J. Macrophages in the murine pancreas and their involvement in fetal endocrine development in vitro. J. Leukoc. Biol. 78, 845–852 (2005).
Cohen, P. E., Nishimura, K., Zhu, L. & Pollard, J. W. Macrophages: important accessory cells for reproductive function. J. Leukoc. Biol. 66, 765–772 (1999).
Cohen, P. E., Chisholm, O., Arceci, R. J., Stanley, E. R. & Pollard, J. W. Absence of colony stimulating factor-1 in osteopetrotic (csfmop/csfmop) mice results in male fertility defects. Biol. Reprod. 55, 310–317 (1996).
Cohen, P. E., Zhu, L. & Pollard, J. W. The absence of CSF-1 in osteopetrotic (csfmop/csfmop) mice disrupts estrous cycles and ovulation. Biol. Reprod. 56, 110–118 (1997).
Brigham, D. E., Little, G., Lukyanenko, Y. O. & Hutson, J. C. Effects of clodronate-containing liposomes on testicular macrophages and Leydig cells in vitro. J. Endocrinol. 155, 87–92 (1997).
Wu, R., Van der Hoek, K. H., Ryan, N. K., Norman, R. J. & Robker, R. L. Macrophage contributions to ovarian function. Hum. Reprod. Update 10, 119–133 (2004).
Brännström, M. & Norman, R. J. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Human Reprod. 8, 1762–1775 (1993).
Cohen, P. E., Hardy, M. P. & Pollard, J. W. Colony-stimulating factor-1 plays a major role in the development of reproductive function in male mice. Mol. Endocrinol. 11, 1636–1650 (1997). This study shows that CSF1-regulated microglial cells help to establish the hypothalamic–pituitary–gonadal axis during development.
Michaelson, M. D. et al. CSF-1 deficiency in mice results in abnormal brain development. Development 122, 1–12 (1996). The first study to indicate that the lack of CSF1 signalling in microglial cells perturbs brain physiology.
Bulloch, K. et al. CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J. Comp. Neurol. 508, 687–710 (2008).
Kondo, Y., Lemere, C. A. & Seabrook, T. J. Osteopetrotic (op/op) mice have reduced microglia, no αβ deposition, and no changes in dopaminergic neurons. J. Neuroinflammation 4, 31 (2007).
Vilhardt, F. Microglia: phagocyte and glia cell. Int. J. Biochem. Cell Biol. 37, 17–21 (2005).
Rapalino, O. et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nature Med. 4, 814–821 (1998).
Lalancette-Hebert, M., Gowing, G., Simard, A., Weng, Y. C. & Kriz, J. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27, 2596–2605 (2007).
Berezovskaya, O., Maysinger, D. & Federoff, S. The hematopoietic cytokine, colony stimulating factor 1, is also a growth factor in the CNS: congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury. Int. J. Dev. Neurosci. 13, 285–299 (1995).
Gottfried-Blackmore, A., Sierra, A., Jellinck, P. H., McEwen, B. S. & Bulloch, K. Brain microglia express steroid-converting enzymes in the mouse. J. Steroid Biochem. Mol. Biol. 109, 96–107 (2008).
Lingen, M. W. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch. Pathol. Lab. Med. 125, 67–71 (2001).
Bergmann, C. E. et al. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J. Leukoc. Biol. 80, 59–65 (2006).
Diez-Roux, G., Argilla, M., Makarenkova, H., Ko, K. & Lang, R. A. Macrophages kill capillary cells in G1 phase of the cell cycle during programmed vascular regression. Development 126, 2141–2147 (1999).
Lobov, I. B. et al. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437, 417–421 (2005).
Rao, S. et al. Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch. Development 134, 4449–4458 (2007). References 69 and 70 show that macrophages are essential for vascular patterning in the eye.
Plaks V. et al. Uterine dendritic cells are crucial for decidua formation during embryo implantation J. Clin. Invest. 118, 3954–3965 (2008). This paper identifies new functions for DCs in angiogenesis during early embryo implantation.
Grunewald, M. et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175–189 (2006).
Ceradini, D. J. et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nature Med. 10, 858–864 (2004).
Levine, J. A., Jensen, M. D., Eberhardt, N. L. & O'Brien, T. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J. Clin. Invest. 101, 1557–1564 (1998).
Wei, S. et al. Modulation of CSF-1-regulated post-natal development with anti-CSF-1 antibody. Immunobiology 210, 109–119 (2005).
Wiktor-Jedrzejczak, W. et al. CSF-1 defeciency in the op/op mouse has differntial effects on macrophage populations and differentiation stages. Exp. Hematol. 20, 1004–1010 (1992).
Gouon-Evans, V. & Pollard, J. W. Unexpected deposition of brown fat in mammary gland during postnatal development. Mol. Endocrinol. 16, 2618–2627 (2002).
Sonnet, C. et al. Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J. Cell Sci. 119, 2497–2507 (2006).
Chazaud, B. et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J. Cell Biol. 163, 1133–1143 (2003).
Bryer, S. C., Fantuzzi, G., Van Rooijen, N. & Koh, T. J. Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J. Immunol. 180, 1179–1188 (2008).
Kawane, K. et al. Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver. Science 292, 1546–1549 (2001). This study identifies a new function for macrophages in erythropoiesis.
Dupasquier, M., Stoitzner, P., van Oudenaren, A., Romani, N. & Leenen, P. J. Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J. Invest. Dermatol. 123, 876–879 (2004).
Smith, S. J., Kotecha, S., Towers, N. & Mohun, T. J. Targeted cell-ablation in Xenopus embryos using the conditional, toxic viral protein M2(H37A). Dev. Dyn. 236, 2159–2171 (2007).
Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303–7311 (2006).
Klimp, A. H., de Vries, E. G., Scherphof, G. L. & Daemen, T. A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol. 44, 143–161 (2002).
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S. & Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today 13, 463–464 (1993). This is a ground-breaking review that suggests that TAMs help tumour growth.
Condeelis, J. & Pollard, J. W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266 (2006).
Mantovani, A., Schioppa, T., Porta, C., Allavena, P. & Sica, A. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev. 25, 315–322 (2006).
Bingle, L., Brown, N. J. & Lewis, C. E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254–265 (2002).
Lin, E. Y., Gouon-Evans, V., Nguyen, A. V. & Pollard, J. W. The macrophage growth factor, CSF-1, in mammary gland development and tumor progression. J. Mammary Gland Biol. Neoplasia 7, 147–162 (2002).
Scholl, S. M. et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J. Natl Cancer Inst. 86, 120–126 (1994).
Murdoch, C., Muthana, M., Coffelt, S. B. & Lewis, C. E. The role of myeloid cells in the promotion of tumour angiogenesis. Nature Rev. Cancer 8, 618–631 (2008).
Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727–740 (2001). This paper shows that macrophages have an important role in promoting tumour progression and metastasis.
Oguma, K. et al. Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells. Embo J. 27, 1671–1681 (2008).
Kimura, Y. N. et al. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis. Cancer Sci. 98, 2009–2018 (2007).
Gazzaniga, S. et al. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J. Invest. Dermatol. 127, 2031–2041 (2007).
Aharinejad, S. et al. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 64, 5378–5384 (2004).
Paulus, P., Stanley, E. R., Schafer, R., Abraham, D. & Aharinejad, S. Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res. 66, 4349–4356 (2006).
Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996).
Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15–18 (2002).
Lin, E. Y. & Pollard, J. W. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 67, 5064–5066 (2007).
Leek, R. D. & Harris, A. L. Tumor-associated macrophages in breast cancer. J. Mammary Gland. Biol. Neoplasia 7, 177–189 (2002).
Lin, E. Y. et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238–11246 (2006).
Lin, E. Y. et al. Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol. Oncol. 1, 288–302 (2007).
Stockmann, C. et al. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456, 814–818 (2008).
De Palma, M., Murdoch, C., Venneri, M. A., Naldini, L. & Lewis, C. E. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 28, 519–524 (2007).
Wyckoff, J. B. et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 67, 2649–2656 (2007).
Wyckoff, J. et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022–7029 (2004).
Pukrop, T. et al. Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc. Natl Acad. Sci. USA 103, 5454–5459 (2006).
Hagemann, T. et al. Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK. J. Immunol. 175, 1197–1205 (2005).
Ojalvo, L. S., King, W., Cox, D. & Pollard, J. W. High density gene expression analysis of tumor associated macrophages from mouse mammary tumors. Am. J. Pathol. 174, 1048–1064 (2009).
Biswas, S. K. et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107, 2112–2122 (2006).
Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A. & Lewis, C. E. Regulation of macrophage function in tumors: the multifaceted role of NF-κB. Blood 26 Jan 2009 (doi:10.1182/blood-2008-12-172825).
Hagemann, T. et al. “Re-educating” tumor-associated macrophages by targeting NF-κB. J. Exp. Med. 205, 1261–1268 (2008).
Balkwill, F., Charles, K. A. & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211–217 (2005).
Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
Gouon-Evans, V., Lin, E. Y. & Pollard, J. W. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res. 4, 155–164 (2002).
Campbell, I. K., Rich, M. J., Bischof, R. J. & Hamilton, J. A. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukoc. Biol. 68, 144–150 (2000).
Babamusta, F. et al. Angiotensin II infusion induces site-specific intra-laminar hemorrhage in macrophage colony-stimulating factor-deficient mice. Atherosclerosis 186, 282–290 (2006).
Motoyoshi, K. Biological activities and clinical application of M-CSF. Int. J. Hematol. 67, 109–122 (1998).
Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796–1808 (2003).
Pang, C. et al. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. Am. J. Physiol. Endocrinol. Metab. 295, E313–E322 (2008).
Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821–1830 (2003).
Lang, P. et al. Monomeric tartrate resistant acid phosphatase induces insulin sensitive obesity. PLoS ONE 3, e1713 (2008).
Patsouris, D. et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell. Metab. 8, 301–309 (2008). Reference 121 and 125 link macrophages with obesity and insulin insensitivity.
Varol, C., Yona, S. & Jung, S. Origins and tissue-context-dependent fates of blood monocytes. Immunol. Cell Biol. 87, 30–38 (2009).
Acknowledgements
I apologize to all authors whose work I could not cite because of space restrictions. J.W.P. is the Louis Goldstein Swan Chair in Women's Cancer Research. His research discussed in this Review is supported by National Institutes of Health grants HD30820, CA131270, CA100324 and the Cancer Center (CA P30-13,330). I thank R. Hynes, Koch Integrative Cancer Center, Massachusetts Institute of Technology, Boston, and C. Stewart, Institute of Molecular Biology, Singapore, for their hospitality towards me during my sabbatical, a period during which this article was written.
Author information
Authors and Affiliations
Corresponding author
Related links
Glossary
- Reticuloendothelial system
-
A classification system, the functional definition of which is based on phagocytosis, that groups macrophages and endothelial cells together.
- Mononuclear phagocytic system
-
The current classification of macrophages, which is an ontological classification based on their bone marrow and monocyte origin.
- Definitive haematopoiesis
-
Haematopoiesis that results in the generation of all blood cell types.
- Osteopetrosis
-
A disease that is associated with the failure to remodel bone, resulting in occluded marrow cavities — literally, 'rock-like' bones.
- Growth plate
-
The area where osteoblasts initiate bone deposition and osteoclasts trigger bone remodelling.
- Liposome-encapsulated clodronate
-
Clodronate (dichloromethylene bisphosphonate) that is encapsulated in liposomes and that is taken up preferentially by macrophages through phagocytosis. The clodronate then kills the macrophages.
- Hypothalamic–pituitary–gonadal axis
-
The feedback system that regulates reproduction through the synthesis of sex steroid hormones in males and females. The highest level of control is in the hypothalamus, a region of the brain that secretes gonadotrophin-releasing hormone, which in turn stimulates the pituitary to produce gonadotrophins that act on the gonads to stimulate sex hormone synthesis.
- Visual evoked potential
-
A neuronal response to repeated visual cues.
- Retinal striate conductance
-
The pathway of neuronal impulses from the retina up the optic nerve to the striatum in the brain. The timing of this is a measure of neuronal conductance from a peripheral organ to the brain.
- Hyaloid vessel system
-
A vessel system that is laid down during the development of the eye and needs to be remodelled to allow unobstructed vision.
- Decidualization
-
The process of stromal transformation in response to an invading embryo in the uterus. The transformed stroma protects and provides sustenance to the embryo and converts into a portion of the placenta as embryonic development proceeds.
- Aortic ring sprouting assay
-
An angiogenic assay that depends on vascular sprouting from small rings of aorta cultured ex vivo.
- Brown fat
-
A type of fat involved in thermogenesis, so called because of the large number of mitochondria that give it its brown colour.
- Polyoma middle T (PyMT) mouse model
-
A transgenic mouse model of breast cancer. The cancer is caused by the restricted expression of the polyoma middle T oncoprotein by mammary epithelial cells, which is under the control of the mouse mammary tumour virus promoter. This model is highly metastatic and recapitulates much of what is seen in human cancers.
- Angiogenic switch
-
The marked increase in vascularization that is observed as benign tumours transition to malignancy.
Rights and permissions
About this article
Cite this article
Pollard, J. Trophic macrophages in development and disease. Nat Rev Immunol 9, 259–270 (2009). https://doi.org/10.1038/nri2528
Issue Date:
DOI: https://doi.org/10.1038/nri2528